Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vivani Medical, Inc. - Common Stock
(NQ:
VANI
)
1.290
-0.020 (-1.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vivani Medical, Inc. - Common Stock
< Previous
1
2
3
Next >
EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia
September 26, 2024
Vivani Medical receives approval for the first human trial of its GLP-1 obesity implant in Australia. The LIBERATE-1 trial will assess safety, tolerability, and weight loss outcomes, with data expected...
Via
Benzinga
EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity
September 04, 2024
Vivani Medical reports promising preclinical liver fat reduction results with its exenatide implant for obesity, showing potential as a differentiated treatment option. The LIBERATE-1 clinical trial is...
Via
Benzinga
VANI Stock Earnings: Vivani Medical Beats EPS for Q2 2024
August 13, 2024
VANI stock results show that Vivani Medical beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Pineapple Financial And 1 Other Stock Under $1 Insiders Are Buying
August 05, 2024
Via
Benzinga
Vivani Medical And 2 Other Stocks Under $2 Insiders Are Buying
August 02, 2024
Via
Benzinga
EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year
July 11, 2024
Vivani Medical plans to start the first clinical study of the NPM-115 program in Australia in Q4 2024. The study will evaluate a 6-month GLP-1 implant for chronic weight management in obese or...
Via
Benzinga
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 13, 2024
Via
Benzinga
Why GLP-1 Developer Vivani Medical's Stock Is Climbing
June 13, 2024
Vivani Medical shares are trading higher Thursday after the company announced the FDA cleared the Investigational New Drug application and lifted the clinical hold on NPM-119.
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 13, 2024
Via
Benzinga
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's NDA Gains FDA Clearance For Clinical Use
June 13, 2024
Vivani Medical cleared FDA for NPM-119 trial in type 2 diabetes. LIBERATE-1 will assess safety, tolerability, & pharmacokinetics. NPM-115 & NPM-139 also in development for weight management.
Via
Benzinga
Exposures
Product Safety
EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use
May 28, 2024
Vivani Medical announced proof-of-concept data for a subdermal exenatide implant designed for feline obesity and diabetes, which was published in BMC Veterinary Research.
Via
Benzinga
VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024
May 13, 2024
VANI stock results show that Vivani Medical met analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
VANI Stock Earnings: Vivani Medical Beats EPS for Q4 2023
March 26, 2024
VANI stock results show that Vivani Medical beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 04, 2024
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 04, 2024
Via
Benzinga
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 01, 2024
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 01, 2024
Via
Benzinga
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
February 28, 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Vivani Medical (VANI) Stock Up 300% Today?
February 28, 2024
With Vivani Medical introducing pre-clinical efficacy data for its weight-loss solution, VANI stock soared on the broader implications.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 28, 2024
Via
Benzinga
Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
February 28, 2024
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Wednesday. The Dow traded down 0.19% to 38,899.92 while the NASDAQ fell 0.31% to 15,985.25. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 28, 2024
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.
Via
Benzinga
Dow Dips 200 Points; TJX Posts Upbeat Sales
February 28, 2024
U.S. stocks traded lower this morning, with the Dow Jones index falling around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.52% to 38,770.83 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 28, 2024
Via
Benzinga
EXCLUSIVE: Vivani Medical Says Weight Loss/Diabetes Implant At Par With Novo Nordisk's Famed Injectable Wegovy/Ozempic, Animal Studies Shows
February 28, 2024
Vivani Medical unveils preclinical data on NPM-115, a twice-yearly exenatide subdermal implant for weight loss. Achieving a 20% reduction in high-fat diet-induced obese mice, comparable to Novo...
Via
Benzinga
Porch Group And 2 Other Stocks Under $3 Insiders Are Buying
February 12, 2024
The Dow Jones index closed lower by more than 50 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Skye Bioscience And 2 Other Penny Stocks Insiders Are Buying
February 05, 2024
The Dow Jones index closed higher by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
PaySign And 3 Other Stocks Under $3 Insiders Are Buying
January 26, 2024
The Dow Jones index closed higher by more than 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Catheter Precision And 2 Other Stocks Under $2 Insiders Are Buying
January 23, 2024
The Dow Jones index closed higher by over 100 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.